CARE Ratings · NSE: CARERATING · BSE: 534804

Q3 FY25 results · Oct–Dec 2024

CARE Ratings reported revenue from operations of ₹96.38 crore (up 22.5% from Q3 FY24) and net profit of ₹28.37 crore (up 18.6% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations96.3878.68+22.5%117.37−17.9%
Other income11.8513.68−13.4%11.86−0.1%
Total income108.2392.36+17.2%129.23−16.2%
Profit before tax38.7233.96+14.0%64.23−39.7%
Net profit for the period28.3723.92+18.6%46.88−39.5%
Attributable to shareholders of the company27.8023.46+18.5%46.09−39.7%
EPS, basic (₹)9.297.88+18.0%15.41−39.7%
Net margin (%)29.430.439.9
Standalone · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations78.5966.68+17.9%101.51−22.6%
Other income11.4310.58+8.0%11.76−2.8%
Total income90.0277.26+16.5%113.27−20.5%
Profit before tax39.3331.73+23.9%66.29−40.7%
Net profit for the period29.4622.23+32.5%49.64−40.6%
EPS, basic (₹)9.857.47+31.9%16.60−40.7%
Net margin (%)37.533.348.9
Consolidated
Filed with BSE
31 Jan 2025, 16:57 IST
Board meeting
30 Jan 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
31 Jan 2025, 16:57 IST
Board meeting
30 Jan 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE